Biomarker indicator testing

Ended Definitive Contract Awarded Last action

Contract number
W81XWH17C0230
Awardee
Awarding agency
Obligated
$525,000

Award facts

Opportunity
Contract value 100% obligated
$525,000.00 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Set-aside
No set-aside
Competition
Not Competed · 1 offer Only One Source
Pricing
Firm Fixed Price
Place of performance
New York, NY 10016, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Other Administrative Action P00001 · Biomarker indicator testing amdin MOD $0
Original award $525,000

About this award

The Department of the Army Medical Command awarded a Firm Fixed Price definitive contract to New York University (NYU) School of Medicine for biomarker indicator testing. The $525,000.00 contract does not have a set-aside designation and was completed on September 17, 2018. NYU School of Medicine is a division of the larger private research university, New York University. Through this contract, NYU School of Medicine provided scientific services, research, and subject matter expertise to the Department of the Army Medical Command.

Quick answers

Who was awarded contract W81XWH17C0230?

W81XWH17C0230 was awarded to New York University by Medical Command (Department of the Army) on September 18, 2017.

How much is contract W81XWH17C0230 worth?

The government has obligated $525,000 on W81XWH17C0230.

Was contract W81XWH17C0230 competed?

The extent of competition for W81XWH17C0230 was not competed. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award